Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Entropy (Basel) ; 25(6)2023 May 29.
Article in English | MEDLINE | ID: mdl-37372210

ABSTRACT

Understanding the dynamics of complex systems defined in the sense of Caputo, such as fractional differences, is crucial for predicting their behavior and improving their functionality. In this paper, the emergence of chaos in complex dynamical networks with indirect coupling and discrete systems, both utilizing fractional order, is presented. The study employs indirect coupling to produce complex dynamics in the network, where the connection between the nodes occurs through intermediate fractional order nodes. The temporal series, phase planes, bifurcation diagrams, and Lyapunov exponent are considered to analyze the inherent dynamics of the network. Analyzing the spectral entropy of the chaotic series generated, the complexity of the network is quantified. As a final step, we demonstrate the feasibility of implementing the complex network. It is implemented on a field-programmable gate array (FPGA), which confirms its hardware realizability.

2.
Diagnostics (Basel) ; 13(6)2023 Mar 22.
Article in English | MEDLINE | ID: mdl-36980502

ABSTRACT

Neutralizing antibodies (NAs) are key immunological markers and are part of the humoral response of the adaptive immune system. NA assays determine the presence of functional antibodies to prevent SARS-CoV-2 infection. We performed a real-world evidence study to detect NAs that confer protection against SARS-CoV-2 after the application of five vaccines (Pfizer/BioNTech, AstraZeneca, Sinovac, Moderna, and CanSino) in the Mexican population. Side effects of COVID-19 vaccines and clinical and demographic factors associated with low immunogenicity were also evaluated. A total of 242 SARS-CoV-2-vaccinated subjects were recruited. Pfizer/BioNTech and Moderna proved the highest percentage of inhibition in a mono-vaccine scheme. Muscular pain, headache, and fatigue were the most common adverse events. None of the patients reported severe adverse events. We found an estimated contagion-free time of 207 (IQR: 182-231) and 187 (IQR: 184-189) days for Pfizer/BioNTech and CanSino in 12 cases in each group. On the basis of our results, we consider that the emerging vaccination strategy in Mexico is effective and safe.

SELECTION OF CITATIONS
SEARCH DETAIL
...